Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor

Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor

CAR-T cells present a highly effective therapeutic option for several malignant diseases, based on their ability to recognize the selected tumor surface marker in an MHC-independent manner. This triggers cell activation and cytokine production, resulting in the killing of the cancerous cell presenti...

Full description

Bibliographic Details
Main Authors:	Duško Lainšček, Anja Golob-Urbanc, Veronika Mikolič, Jelica Pantović-Žalig, Špela Malenšek, Roman Jerala
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Molecular Therapy: Oncolytics
Subjects:	CD19 CAR-T cells cancer immunotherapy heterodimerization system pharmacological control NFAT artificial transcription factors
Online Access:	http://www.sciencedirect.com/science/article/pii/S237277052300030X

Similar Items

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
by: Leonardo M. R. Ferreira, et al.
Published: (2021-11-01)

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
by: Yannick D. Muller, et al.
Published: (2021-03-01)

Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing
by: Duško Lainšček, et al.
Published: (2022-06-01)

NFAT1 and NFAT2 Differentially Regulate CTL Differentiation Upon Acute Viral Infection
by: Tianhao Xu, et al.
Published: (2019-02-01)

A Novel T Cell-Engaging Bispecific Antibody for Treating Mesothelin-Positive Solid Tumors
by: Aerin Yoon, et al.
Published: (2020-03-01)

Store-Operated Calcium Entry: Shaping the Transcriptional and Epigenetic Landscape in Pancreatic Cancer
by: Ana P. Kutschat, et al.
Published: (2021-04-01)

YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity
by: Wing Lam, et al.
Published: (2023-01-01)

Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma
by: Patrick Nasarre, et al.
Published: (2021-05-01)

Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR)
by: Nicola Mitwasi, et al.
Published: (2022-04-01)

Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia
by: Simon Loff, et al.
Published: (2020-06-01)

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
by: Wenjie Li, et al.
Published: (2023-03-01)

Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias
by: Elisaveta Voynova, et al.
Published: (2022-01-01)

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
by: Ahmed Abbasi, et al.
Published: (2020-01-01)

Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function
by: Jingjie Chang, et al.
Published: (2023-08-01)

NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells
by: Yibin Lin, et al.
Published: (2023-09-01)

Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
by: Yuan Meng, et al.
Published: (2021-06-01)

Where it all started
by: Long Zhang, et al.
Published: (2023-04-01)

Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains
by: Tiffany Smith, et al.
Published: (2021-07-01)

Improving prediction of heterodimeric protein complexes using combination with pairwise kernel
by: Peiying Ruan, et al.
Published: (2018-02-01)

Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling
by: Shu-Fen Wu, et al.
Published: (2017-08-01)

Role of CD14 in host protection against infections and in metabolism regulation
by: Francesca eGranucci, et al.
Published: (2013-07-01)

Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo
by: Jin-Yuan Ho, et al.
Published: (2021-06-01)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
by: Yan Yang, et al.
Published: (2020-09-01)

CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
by: Lihe Su, et al.
Published: (2022-12-01)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo
by: Susana Pascoal, et al.
Published: (2020-02-01)

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
by: Guillermo Ureña-Bailén, et al.
Published: (2022-10-01)

Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions
by: Julia Sajman, et al.
Published: (2023-09-01)

Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
by: Hongxia Wang, et al.
Published: (2021-08-01)

The role of FOXO4/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease
by: Hongbiao Huang, et al.
Published: (2023-01-01)

CRISPRa-mediated FOXP3 gene upregulation in mammalian cells
by: Vida Forstnerič, et al.
Published: (2019-11-01)

TCR Dependent Metabolic Programming Regulates Autocrine IL-4 Production Resulting in Self-Tuning of the CD8+ T Cell Activation Setpoint
by: Kali F. Crofts, et al.
Published: (2020-03-01)

Recyclable magnetite-silver heterodimer nanocomposites with durable antibacterial performance
by: Chunyan Yong, et al.
Published: (2018-03-01)

Mechanisms of NURR1 Regulation: Consequences for Its Biological Activity and Involvement in Pathology
by: Ángel Juan García-Yagüe, et al.
Published: (2023-07-01)

Cloning of the gabaB Receptor Subunits B1 and B2 and their Expression in the Central Nervous System of the Adult Sea Lamprey
by: Daniel Romaus-Sanjurjo, et al.
Published: (2016-12-01)

Letter to the Editor: No folding upon binding of intrinsically disordered proteins: Still interesting but not unique and novel. A commentary on “A novel mode of interaction between intrinsically disordered proteins. by Hibino, E. and Hoshino, M., Biophysics and Physicobiology 17, 86–93 (2020). DOI: 10.2142/biophysico.BSJ-2020012”
by: Alexander B. Sigalov
Published: (2020-12-01)

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab
by: Jung Won Shin, et al.
Published: (2019-10-01)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
by: Mei Mikawa, et al.
Published: (2022-07-01)

NFAT2 regulates generation of innate-like CD8+ T lymphocytes and CD8+ T lymphocytes responses
by: Emilia Pachulec, et al.
Published: (2016-10-01)

CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting
by: Qiusha Huang, et al.
Published: (2023-03-01)

Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality
by: Richard Smith, et al.
Published: (2023-07-01)